Telomir Pharmaceuticals, Inc. Common Stock
General ticker "TELO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $81.4M (TTM average)
Telomir Pharmaceuticals, Inc. Common Stock does not follow the US Stock Market performance with the rate: -26.7%.
Estimated limits based on current volatility of 3.4%: low 1.24$, high 1.32$
Factors to consider:
- Total employees count: 15 as of 2023
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [0.80$, 2.65$]
- 2026-12-31 to 2027-12-31 estimated range: [0.73$, 2.38$]
Short-term TELO quotes
Long-term TELO plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $3.94MM | $12.24MM | $10.54MM |
| Operating Income | $-3.94MM | $-12.24MM | $-10.54MM |
| Non-Operating Income | $-9.13MM | $-4.29MM | $0.13MM |
| Interest Expense | $1.64MM | $4.34MM | $0.00MM |
| R&D Expense | $1.57MM | $2.24MM | $2.44MM |
| Income(Loss) | $-13.07MM | $-16.53MM | $-10.41MM |
| Profit(Loss)* | $-13.07MM | $-16.53MM | $-10.41MM |
| Stockholders Equity | $3.44MM | $0.64MM | $5.91MM |
| Assets | $4.77MM | $1.32MM | $7.34MM |
| Operating Cash Flow | $-3.86MM | $-5.07MM | $-3.69MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $3.86MM | $6.34MM | $9.71MM |
| Earnings Per Share** | $-0.44 | $-0.56 | $-0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.